| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 33.821 | 62.552 | 55.299 | 52.852 | 46.542 | - | - | - | - | - |
| Total Income - EUR | 33.821 | 62.552 | 55.299 | 60.552 | 46.546 | - | - | - | - | - |
| Total Expenses - EUR | 16.171 | 11.412 | 13.767 | 14.337 | 10.318 | - | - | - | - | - |
| Gross Profit/Loss - EUR | 17.650 | 51.139 | 41.533 | 46.215 | 36.228 | - | - | - | - | - |
| Net Profit/Loss - EUR | 16.642 | 49.508 | 40.783 | 45.610 | 35.626 | - | - | - | - | - |
| Employees | 1 | 1 | 1 | 1 | 1 | - | - | - | - | - |
Check the financial reports for the company - Biomedmun Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 1.053 | 717 | - | - | - | - | - |
| Current Assets | 41.182 | 24.211 | 35.489 | 85.117 | 69.993 | - | - | - | - | - |
| Inventories | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - |
| Receivables | 30.162 | 18.739 | 32.143 | 64.929 | 61.860 | - | - | - | - | - |
| Cash | 11.020 | 5.472 | 3.346 | 20.188 | 8.133 | - | - | - | - | - |
| Shareholders Funds | 15.278 | 15.122 | 17.412 | 62.703 | 35.676 | - | - | - | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | - | - | - | - | - |
| Debts | 25.904 | 9.089 | 18.076 | 23.467 | 35.034 | - | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Biomedmun Srl